The handful of buildings in the private city of Próspera line a single road. Hamaili looks at the barrier, which sits on the ...
GMA Network on MSN
Five young scientists present studies at NAST competition
Five young Filipino researchers from different universities presented their studies as part of the 2026 NAST Talent Search for Young Scientists (NTSYS). NTSYS was established in 1991 with the goal of ...
In the delicate and deeply personal journey toward parenthood, hope is everything. For nearly 14 years, Kato Repro Biotech Center has stood as a beacon of hope by combining world-renowned Japanese ...
A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...
Big Pharma is on the prowl for biotech companies, but it’s acting stingy. Deal sizes are smaller, valuations are reasonable and buyers are walking away from megadeals when sellers push too hard on ...
The University of Texas at Austin and the Welch Foundation invite you to a distinguished lecture by Dr. Robert S. Langer, Institute Professor at MIT and a leading innovator in biomaterials and ...
OceanaGold posts record Q1 results on strong gold prices, buybacks, and NYSE listing; valuation is still low with rising ...
Welcome to Fierce Biotech’s fifth annual layoff tracker, a resource designed to keep pace with the sector’s steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...
With its breathtaking beaches, rich culture and generous hospitality, the Philippines is a dream destination for travelers and digital nomads. But what does it mean to be wealthy in this Southeast ...
Tempus is a technology company leading the adoption of AI to advance precision medicine and patient care. We bring together one of the world’s largest libraries of multimodal clinical and molecular ...
Finding innovative ways to treat cancer is Pfizer’s biggest priority so to boost cutting-edge technologies, Pfizer executives went to Shenyang, China. There, last summer, Pfizer paid $1.25 billion to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results